Alder Biopharmaceuticals (NASDAQ:ALDR) reports that Chief Business Officer, Treasurer and Secretary Mark Litton will leave the company on August 1 to pursue another opportunity. He has agreed to serve as a consultant for 12 months from the date of his departure.